Skip to main content
ATEC
NASDAQ Industrial Applications And Services

Alphatec Q3: First Quarterly Operating Profit, but Cash Falls to $79.9M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$7.9
Mkt Cap
$1.756B
52W Low
$6.82
52W High
$23.29
52W Position info
16% above low
Off High info
66% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

ATEC sits 16% above its 52-week low of $6.82 on elevated volume (2.9× avg).

Summary

Alphatec posted its first quarterly operating profit ($3.2 million) on $221.2 million of revenue, up 13%, while cash fell to $79.9 million from $160.8 million at year-end after heavy instrument spending and the $63.3 million payoff of its 2026 Notes.


Key Events · Earnings and Guidance · ATEC

  • Q3 Revenue Up 13% to $221.2M

    Revenue rose to $221.2 million from $196.5 million a year ago; nine-month revenue was $626.8 million, up 14% from $551.2 million.

  • First Quarterly Operating Profit

    Operating income of $3.2 million versus a $15.9 million operating loss in Q3 2025; net loss narrowed to $5.5 million ($0.03 per share) from $28.6 million ($0.19).

  • Cash Falls to $79.9M

    Cash and equivalents dropped from $160.8 million at December 31, 2025 to $79.9 million, despite $40.7 million of nine-month operating cash flow, after $64.4 million of investing outflows and the $63.3 million 2026 Notes repayment.

  • Debt Stack Refinanced and Covenants Met

    Outstanding debt is a $173.9 million JPM term loan, $70.0 million JPM revolver and $405.0 million of 0.75% 2030 Notes; the company states it is in compliance with all financial covenants as of September 30, 2026.


Analysis · ATEC · Industrial Applications And Services

The headline is Alphatec's first quarterly operating profit: $3.2 million in Q3 versus a $15.9 million operating loss a year ago, with the net loss narrowing to $5.5 million ($0.03 per share) from $28.6 million ($0.19). The offset is cash, which fell to $79.9 million from $160.8 million at year-end 2025. Two drains explain the drop: $64.4 million of investing outflows (surgical instruments, intangibles, a $5.0 million note receivable) and the $63.3 million cash repayment of the remaining 2026 Notes on July 30, 2026. Nine-month operating cash flow of $40.7 million was positive but did not cover that spending. The debt stack now consists of a $173.9 million JPM term loan, a $70.0 million revolver and $405.0 million of 0.75% 2030 Notes, and the company states it is in compliance with its leverage and fixed-charge covenants as of September 30, 2026. Management considers existing funds, operating cash and available financing adequate — but the shrinking cash balance is the number to weigh against the improving P&L.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ATEC was trading at $7.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $6.82 to $23.29. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEC - Latest Insights

ATEC
Oct 29, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
ATEC
Sep 10, 2026, 8:58 PM EDT
Filing Type: 4
Importance Score:
7
ATEC
Aug 04, 2026, 4:57 PM EDT
Filing Type: 10-Q
Importance Score:
7
ATEC
Aug 04, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
ATEC
Jun 11, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8